143 related articles for article (PubMed ID: 25262158)
21. Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma.
Marc MM; Korosec P; Kosnik M; Kern I; Flezar M; Suskovic S; Sorli J
Am J Respir Cell Mol Biol; 2004 Aug; 31(2):216-9. PubMed ID: 15039137
[TBL] [Abstract][Full Text] [Related]
22. Pulp progenitor cell recruitment is selectively guided by a C5a gradient.
Chmilewsky F; Jeanneau C; Laurent P; Kirschfink M; About I
J Dent Res; 2013 Jun; 92(6):532-9. PubMed ID: 23603337
[TBL] [Abstract][Full Text] [Related]
23. Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2008 May; 117(5):343-6. PubMed ID: 17995989
[TBL] [Abstract][Full Text] [Related]
24. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
25. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
[TBL] [Abstract][Full Text] [Related]
26. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
[TBL] [Abstract][Full Text] [Related]
27. Complement system activation during orthotopic liver transplantation in man. Indications of peroperative complement system activation in the gut.
Rønholm E; Tomasdottir H; Runeborg J; Bengtsson A; Bengtson JP; Stenqvist O; Friman S
Transplantation; 1994 Jun; 57(11):1594-7. PubMed ID: 8009593
[TBL] [Abstract][Full Text] [Related]
28. Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo.
Hetland G; Moen O; Bergh K; Högäsen K; Hack CE; Mollnes TE; Fosse E
Ann Thorac Surg; 1997 Apr; 63(4):1076-80. PubMed ID: 9124908
[TBL] [Abstract][Full Text] [Related]
29. Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
Kuroda H; Fujihara K; Takano R; Takai Y; Takahashi T; Misu T; Nakashima I; Sato S; Itoyama Y; Aoki M
J Neuroimmunol; 2013 Jan; 254(1-2):178-82. PubMed ID: 23017732
[TBL] [Abstract][Full Text] [Related]
30. Expression of receptors for anaphylatoxins C3a and C5a on rat islet preparations.
Tokodai K; Goto M; Inagaki A; Imura T; Nakanishi W; Satomi S
Transplant Proc; 2011 Nov; 43(9):3179-80. PubMed ID: 22099750
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
32. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
Zoccolella S; Simone IL; Lamberti P; Samarelli V; Tortelli R; Serlenga L; Logroscino G
Neurology; 2008 Jan; 70(3):222-5. PubMed ID: 18195267
[TBL] [Abstract][Full Text] [Related]
33. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
34. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
[TBL] [Abstract][Full Text] [Related]
35. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
36. The release of C5a in complement-activated serum does not require C6.
Biesecker G; Wagner JL; Hugli TE
J Immunol; 1989 Aug; 143(4):1228-32. PubMed ID: 2545783
[TBL] [Abstract][Full Text] [Related]
37. Anaphylatoxin levels in human vitreous humor.
Mondino BJ; Sidikaro Y; Sumner H
Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1195-8. PubMed ID: 3262096
[TBL] [Abstract][Full Text] [Related]
38. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
39. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
[TBL] [Abstract][Full Text] [Related]
40. Relative inefficiency of terminal complement activation.
Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
